JPWO2023145804A5 - - Google Patents

Info

Publication number
JPWO2023145804A5
JPWO2023145804A5 JP2023576967A JP2023576967A JPWO2023145804A5 JP WO2023145804 A5 JPWO2023145804 A5 JP WO2023145804A5 JP 2023576967 A JP2023576967 A JP 2023576967A JP 2023576967 A JP2023576967 A JP 2023576967A JP WO2023145804 A5 JPWO2023145804 A5 JP WO2023145804A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
substituent
substituents selected
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023576967A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023145804A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/002387 external-priority patent/WO2023145804A1/ja
Publication of JPWO2023145804A1 publication Critical patent/JPWO2023145804A1/ja
Publication of JPWO2023145804A5 publication Critical patent/JPWO2023145804A5/ja
Pending legal-status Critical Current

Links

JP2023576967A 2022-01-27 2023-01-26 Pending JPWO2023145804A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022011030 2022-01-27
PCT/JP2023/002387 WO2023145804A1 (ja) 2022-01-27 2023-01-26 新規なb0at1阻害剤

Publications (2)

Publication Number Publication Date
JPWO2023145804A1 JPWO2023145804A1 (https=) 2023-08-03
JPWO2023145804A5 true JPWO2023145804A5 (https=) 2026-02-25

Family

ID=87471506

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023576967A Pending JPWO2023145804A1 (https=) 2022-01-27 2023-01-26

Country Status (7)

Country Link
US (1) US20250170126A1 (https=)
EP (1) EP4470533A4 (https=)
JP (1) JPWO2023145804A1 (https=)
CN (1) CN118678949A (https=)
AR (1) AR128348A1 (https=)
TW (1) TW202346276A (https=)
WO (1) WO2023145804A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024210198A1 (https=) 2023-04-06 2024-10-10

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103025307B (zh) * 2010-06-30 2017-03-29 雀巢产品技术援助有限公司 菊苣酸及衍生物用于调节皮肤色素沉着的用途
CA2803461C (en) * 2010-06-30 2018-09-25 Nestec S.A. Use of caftaric acid and derivatives in food supplement for regulating skin pigmentation
UA111756C2 (uk) 2011-11-03 2016-06-10 Ф. Хоффманн-Ля Рош Аг Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
WO2020210662A1 (en) * 2019-04-11 2020-10-15 The Scripps Research Institute Small molecules for cancer therapy that reduce the expression of transcription factors klf5 and egr-1
US11155528B2 (en) 2019-10-25 2021-10-26 King Abdulaziz University Bis-propenamide compounds and methods of treating cancer
KR102647513B1 (ko) * 2019-10-30 2024-03-14 경성대학교 산학협력단 Fxr 활성효과를 가지는 시나믹아마이드 유도체, 이를 유효성분으로 함유하는 약학적 조성물 및 이의 제조방법
JP7423453B2 (ja) 2020-06-29 2024-01-29 マクセル株式会社 マッサージ装置

Similar Documents

Publication Publication Date Title
CA2817317C (en) Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
JP2022527796A5 (https=)
JP7399848B2 (ja) Rho関連コイルドコイル含有プロテインキナーゼの阻害剤
JP2011507854A5 (https=)
JP2019516759A (ja) がんの処置のためのピラゾロピリジン誘導体
JP2009532452A5 (https=)
CN103370320B (zh) 芳基氨基醇取代的2,3-二氢咪唑并[1,2-c]喹啉
JP2016537384A5 (https=)
TW202039459A (zh) Alk5 抑制劑
JP2019512535A5 (https=)
JP2019530725A5 (https=)
JP2004526699A5 (https=)
US9730943B2 (en) Alkoxy-substituted 2,3-dihydroimidazo[1,2-C]quinazolines
JP2017528515A5 (https=)
JPWO2023145804A5 (https=)
JP2019504102A5 (https=)
JP2019512534A5 (https=)
JP2024506047A5 (https=)
US20210128555A1 (en) Cdk4/6 inhibitors and use thereof
JPWO2021141041A5 (https=)
JP2025508473A5 (https=)
HK1180685B (en) Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
HK1190712B (en) Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-c]quinolines
EA039344B1 (ru) Гетероциклическое соединение в качестве ингибитора jak и его соли и терапевтическое применение
HK1189594A (en) Alkoxy-substituted 2,3-dihydroimidazo[1,2-c]quinazolines